Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway

Patients with non-small cell lung cancer (NSCLC) can develop strong drug resistance following long-term treatment with platinum-based drugs. Increasing doses of chemotherapeutic drugs fail to obtain better results, and serious complications occur. It has been demonstrated that upregulation of excisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yun, Hong, Chaojin, Chen, Xiaochen, Qin, Zhiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491090/
https://www.ncbi.nlm.nih.gov/pubmed/32963615
http://dx.doi.org/10.3892/ol.2020.12072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491090/
https://www.ncbi.nlm.nih.gov/pubmed/32963615
http://dx.doi.org/10.3892/ol.2020.12072

Ejemplares similares